JP Morgan Chase’s Molecular Partners MOLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$61 Buy
+15
New +$62 ﹤0.01% 7883
2024
Q1
– Sell
-1
Closed -$4 – 7704
2023
Q4
$4 Buy
+1
New +$4 ﹤0.01% 7457

Other funds holding MOLN

JP Morgan Chase's MOLN Position: Q3 2026 in Review

JP Morgan Chase opened a new position in Molecular Partners (MOLN) in Q3 2026: 15 shares worth $61. The stake represents ﹤0.01% of the portfolio and ranks #7883 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in MOLN as recently as Q4 2023.

JP Morgan Chase first reported a position in MOLN in Q4 2023 and has held it in 2 quarters since. 7 funds tracked by Wall St. Rank hold MOLN as of Q3 2026.

  • JP Morgan Chase held 15 shares of Molecular Partners worth $61 as of Q3 2026.
  • Molecular Partners was a new JP Morgan Chase position in Q3 2026.
  • Molecular Partners made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #7883 holding.
  • JP Morgan Chase first reported a position in Molecular Partners in Q4 2023 and has held it in 2 quarters since.
  • 7 funds tracked by Wall St. Rank held Molecular Partners as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.